Jérôme Galon

68.8k total citations · 15 hit papers
239 papers, 39.6k citations indexed

About

Jérôme Galon is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Jérôme Galon has authored 239 papers receiving a total of 39.6k indexed citations (citations by other indexed papers that have themselves been cited), including 190 papers in Oncology, 125 papers in Immunology and 46 papers in Molecular Biology. Recurrent topics in Jérôme Galon's work include Cancer Immunotherapy and Biomarkers (139 papers), Immunotherapy and Immune Responses (81 papers) and Colorectal Cancer Treatments and Studies (46 papers). Jérôme Galon is often cited by papers focused on Cancer Immunotherapy and Biomarkers (139 papers), Immunotherapy and Immune Responses (81 papers) and Colorectal Cancer Treatments and Studies (46 papers). Jérôme Galon collaborates with scholars based in France, United States and Belgium. Jérôme Galon's co-authors include Wolf H. Fridman, Franck Pagès, Bernhard Mlecnik, Daniela Bruni, Gabriela Bindea, Catherine Sautès‐Fridman, Amos Kirilovsky, Zlatko Trajanoski, Marie Tosolini and Helen K. Angell and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Jérôme Galon

229 papers receiving 39.2k citations

Hit Papers

Type, Density, and Locati... 2005 2026 2012 2019 2006 2009 2012 2013 2019 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
    2006 4.8k citations Jérôme Galon, Anne Costes et al. profile →
  2. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks
    2009 4.6k citations Gabriela Bindea, Bernhard Mlecnik et al. profile →
  3. The immune contexture in human tumours: impact on clinical outcome
    2012 3.5k citations Wolf H. Fridman, Franck Pagès et al. profile →
  4. Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
    2013 2.9k citations Gabriela Bindea, Bernhard Mlecnik et al. profile →
  5. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
    2019 2.3k citations Jérôme Galon, Daniela Bruni Nature Reviews Drug Discovery profile →
  6. Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
    2005 1.6k citations Franck Pagès, Anne Berger et al. profile →
  7. The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
    2020 1.0k citations Daniela Bruni, Helen K. Angell et al. profile →
  8. Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer
    2011 877 citations Marie Tosolini, Amos Kirilovsky et al. Cancer Research profile →
  9. CluePedia Cytoscape plugin: pathway insights using integrated experimental and in silico data
    2013 831 citations Gabriela Bindea, Jérôme Galon et al. profile →
  10. Immune infiltration in human tumors: a prognostic factor that should not be ignored
    2009 805 citations Franck Pagès, Jérôme Galon et al. profile →
  11. Histopathologic-Based Prognostic Factors of Colorectal Cancers Are Associated With the State of the Local Immune Reaction
    2011 765 citations Bernhard Mlecnik, Marie Tosolini et al. profile →
  12. In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer
    2009 724 citations Franck Pagès, Amos Kirilovsky et al. profile →
  13. The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures
    2013 620 citations Jérôme Galon, Helen K. Angell et al. profile →
  14. From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in cancer
    2013 418 citations Helen K. Angell, Jérôme Galon profile →
  15. Tumor Immunology and Tumor Evolution: Intertwined Histories
    2020 377 citations Jérôme Galon, Daniela Bruni profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jérôme Galon 22.4k 19.0k 11.3k 6.0k 5.4k 239 39.6k
Frances R. Balkwill 22.5k 1.0× 18.4k 1.0× 14.1k 1.2× 4.6k 0.8× 9.6k 1.8× 294 46.9k
Paola Allavena 22.0k 1.0× 33.3k 1.8× 14.6k 1.3× 4.9k 0.8× 6.9k 1.3× 295 56.8k
Antonio Sica 15.2k 0.7× 22.6k 1.2× 12.3k 1.1× 3.8k 0.6× 6.8k 1.3× 142 42.0k
Dmitry I. Gabrilovich 25.8k 1.1× 41.6k 2.2× 15.6k 1.4× 4.3k 0.7× 5.9k 1.1× 266 57.3k
Zlatko Trajanoski 11.7k 0.5× 9.3k 0.5× 11.0k 1.0× 4.7k 0.8× 5.0k 0.9× 194 28.3k
Ash A. Alizadeh 11.0k 0.5× 10.6k 0.6× 15.5k 1.4× 8.6k 1.4× 9.5k 1.8× 251 35.5k
Thomas F. Gajewski 19.8k 0.9× 20.9k 1.1× 11.9k 1.1× 3.1k 0.5× 2.5k 0.5× 321 36.1k
Wolf H. Fridman 27.6k 1.2× 31.2k 1.6× 16.6k 1.5× 8.5k 1.4× 7.0k 1.3× 529 57.4k
Franck Pagès 14.7k 0.7× 11.4k 0.6× 6.9k 0.6× 4.0k 0.7× 3.7k 0.7× 101 25.1k
David A. Tuveson 21.2k 0.9× 7.5k 0.4× 19.6k 1.7× 4.8k 0.8× 9.4k 1.7× 200 41.1k

Countries citing papers authored by Jérôme Galon

Since Specialization
Citations

This map shows the geographic impact of Jérôme Galon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérôme Galon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérôme Galon more than expected).

Fields of papers citing papers by Jérôme Galon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jérôme Galon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérôme Galon. The network helps show where Jérôme Galon may publish in the future.

Co-authorship network of co-authors of Jérôme Galon

This figure shows the co-authorship network connecting the top 25 collaborators of Jérôme Galon. A scholar is included among the top collaborators of Jérôme Galon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jérôme Galon. Jérôme Galon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Locke, Frederick L., Nathalie Scholler, Mike Mattie, et al.. (2025). Facts and Hopes: CAR T-Cell Therapy and Immune Contexture in Non-Hodgkin Lymphoma. Clinical Cancer Research. 31(18). 3834–3843.
2.
Iosif, Christina, et al.. (2025). Partial transvenous embolization as an intermediate strategy for large brain arteriovenous malformations: A technical note. Journal of NeuroInterventional Surgery. 18(1). 41–46.
3.
4.
Secrier, Maria, Lara McGrath, Felicia Ng, et al.. (2023). Immune Cell Abundance and T-cell Receptor Landscapes Suggest New Patient Stratification Strategies in Head and Neck Squamous Cell Carcinoma. Cancer Research Communications. 3(10). 2133–2145. 7 indexed citations
5.
Antoniotti, Carlotta, et al.. (2023). Light on life: immunoscore immune-checkpoint, a predictor of immunotherapy response. OncoImmunology. 12(1). 2243169–2243169. 15 indexed citations
6.
Rapoport, Bernardo L., Simon Nayler, Bernhard Mlecnik, et al.. (2022). Tumor-Infiltrating Lymphocytes (TILs) in Early Breast Cancer Patients: High CD3+, CD8+, and Immunoscore Are Associated with a Pathological Complete Response. Cancers. 14(10). 2525–2525. 18 indexed citations
7.
Ascierto, Paolo A., Carlo Bifulco, Fortunato Ciardiello, et al.. (2021). Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd–3rd, 2020, Italy). Journal of Translational Medicine. 19(1). 238–238. 3 indexed citations
8.
Ascierto, Paolo A., Francesco M. Marincola, Bernard A. Fox, & Jérôme Galon. (2020). No time to die: the consensus immunoscore for predicting survival and response to chemotherapy of locally advanced colon cancer patients in a multicenter international study. OncoImmunology. 9(1). 1826132–1826132. 11 indexed citations
9.
Ottaiano, Alessandro, Michele Caraglia, Annabella Di Mauro, et al.. (2020). Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer. Cancers. 12(10). 3073–3073. 24 indexed citations
10.
Galon, Jérôme & Daniela Bruni. (2019). Approaches to treat immune hot, altered and cold tumours with combination immunotherapies. Nature Reviews Drug Discovery. 18(3). 197–218. 2343 indexed citations breakdown →
11.
Ascierto, Paolo A., James Brugarolas, Luigi Buonaguro, et al.. (2018). Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy). Journal for ImmunoTherapy of Cancer. 6(1). 69–69. 9 indexed citations
12.
Angelova, Mihaela, Pornpimol Charoentong, Hubert Hackl, et al.. (2015). Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy. Genome Biology. 16(1). 64–64. 387 indexed citations
13.
Teng, Michele W.L., Jérôme Galon, Wolf H. Fridman, & Mark J. Smyth. (2015). From mice to humans: developments in cancer immunoediting. Journal of Clinical Investigation. 125(9). 3338–3346. 244 indexed citations
14.
Bloy, Norma, Aitziber Buqué, Fernando Aranda, et al.. (2015). Trial watch: Naked and vectored DNA-based anticancer vaccines. OncoImmunology. 4(5). e1026531–e1026531. 32 indexed citations
15.
Aniței, Maria-Gabriela, Guy Zeitoun, Bernhard Mlecnik, et al.. (2014). Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer. Clinical Cancer Research. 20(7). 1891–1899. 282 indexed citations
16.
Bloy, Norma, Jonathan Pol, Gwenola Manic, et al.. (2014). Trial Watch: Radioimmunotherapy for oncological indications. OncoImmunology. 3(9). e954929–e954929. 47 indexed citations
17.
Tosolini, Marie, Amos Kirilovsky, Bernhard Mlecnik, et al.. (2011). Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer. Cancer Research. 71(4). 1263–1271. 877 indexed citations breakdown →
18.
Camus, Matthieu, Marie Tosolini, Bernhard Mlecnik, et al.. (2009). Coordination of Intratumoral Immune Reaction and Human Colorectal Cancer Recurrence. Cancer Research. 69(6). 2685–2693. 226 indexed citations
19.
Cassard, Lydie, Joël F.G. Cohen-Solal, Annie Galinha, et al.. (2002). Modulation of tumor growth by inhibitory Fcγ receptor expressed by human melanoma cells. Journal of Clinical Investigation. 110(10). 1549–1557. 25 indexed citations
20.
Vely, Frédéric, Nadège Gruel, Janine Moncuit, et al.. (1997). A New Set of Monoclonal Antibodies Against Human FcγRII (CD32) and FcγRIII (CD16): Characterization and Use in Various Assays. Hybridoma. 16(6). 519–528. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frances R. Balkwill Breakdown of academic impact, for papers by Paola Allavena Breakdown of academic impact, for papers by Antonio Sica Breakdown of academic impact, for papers by Dmitry I. Gabrilovich Breakdown of academic impact, for papers by Zlatko Trajanoski Breakdown of academic impact, for papers by Ash A. Alizadeh Breakdown of academic impact, for papers by Thomas F. Gajewski Breakdown of academic impact, for papers by Wolf H. Fridman Breakdown of academic impact, for papers by Franck Pagès Breakdown of academic impact, for papers by David A. Tuveson
Rankless by CCL
2026